Table 1.

Patient demographics and disease stage

Pseudonym	Gender	Age	Stage	M protein type
MM1	F	60	Newly diagnosed, prior to first therapy	IgG κ
MM2	F	69	Newly diagnosed, prior to first therapy	IgG κ
MM3	M	64	Newly diagnosed, prior to first therapy	κ light chain
MM4	F	71	Relapsed, prior to start of 6th line therapy	IgG λ
MM5	M	66	Relapsed, prior to start of 6th line therapy	λ light chain
MM6	M	64	Relapsed, prior to 2nd line of therapy	IgG κ
MM7	F	71	Relapsed, prior to 2nd line of therapy	κ light chain
MM8	M	56	Relapsed, prior to 2nd line of therapy	IgA κ
MM9	F	31	High-risk SMM	IgG λ
MM10	M	53	MGUS	IgM κ

MGUS monoclonal gammopathy of undetermined significance, SMM smoldering multiple myeloma